RP

Robert Postma

Director at Alaunos Therapeutics

For over two decades, Mr. Postma has served as the principal of WaterMill Asset Management, an asset management firm which he founded that actively trades in municipal bonds and equities. Mr. Postma has valuable relationships with prospective financial partners and brings a strong ownership perspective to Ziopharm’s boardroom, as WaterMill is one of the largest, long-term shareholders of the Company. In addition, he brings over four decades of experience investing across the equity and fixed income markets and frequently analyzes, invests in and engages with healthcare and biotechnology companies. Mr. Postma holds a Bachelor of Arts degree in Business and Economics from Lafayette College.

Timeline

  • Director

    February 5, 2021 - present